| P2093 | author name string | Alvin H Schmaier | |
| P2860 | cites work | Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R) | Q24313325 |
| | Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor | Q24320005 |
| | Defective thrombus formation in mice lacking coagulation factor XII | Q24646366 |
| | A human intracellular apyrase-like protein, LALP70, localizes to lysosomal/autophagic vacuoles | Q28115150 |
| | The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface | Q28115496 |
| | Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney | Q28118209 |
| | Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis | Q28508572 |
| | Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization | Q28573785 |
| | Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes | Q28628970 |
| | Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator | Q28628991 |
| | High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation | Q28631409 |
| | High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation | Q28631465 |
| | Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. | Q30362649 |
| | Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation | Q30479254 |
| | Recombinant prolylcarboxypeptidase activates plasma prekallikrein | Q30756983 |
| | Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells | Q32081348 |
| | Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator | Q34112923 |
| | The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin | Q34155709 |
| | Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients | Q34269759 |
| | Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages | Q34301414 |
| | Polyphosphate modulates blood coagulation and fibrinolysis. | Q34304738 |
| | The expression of high molecular weight kininogen on human umbilical vein endothelial cells | Q34408819 |
| | Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia | Q34522885 |
| | Human neutrophils contain and bind high molecular weight kininogen | Q34576164 |
| | Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor | Q34790892 |
| | Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma | Q35037706 |
| | The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction | Q35148421 |
| | High molecular weight kininogen binds to unstimulated platelets | Q35808722 |
| | Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin | Q35849803 |
| | The intrinsic pathway of coagulation: a target for treating thromboembolic disease? | Q36771762 |
| | Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells | Q37026019 |
| | A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease | Q37361142 |
| | Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor | Q37372571 |
| | Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells | Q40615036 |
| | High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells | Q40874868 |
| | Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways | Q41940728 |
| | Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects | Q44019600 |
| | Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study | Q44123484 |
| | The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells | Q44565949 |
| | Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively | Q45063820 |
| | Gene trapping methods for the identification and functional analysis of cell surface proteins in mice | Q46085169 |
| | Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells | Q46661267 |
| | Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor | Q46988574 |
| | Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells | Q47392112 |
| | Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice | Q48939342 |
| | Plasma levels of bradykinin are suppressed in factor XII-deficient mice. | Q51802842 |
| | Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis | Q72057062 |
| | Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease | Q73265449 |
| | Factor XI assembly and activation on human umbilical vein endothelial cells in culture | Q73769063 |
| | Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix | Q74586174 |
| | Factor XII does not initiate prekallikrein activation on endothelial cells | Q74823530 |
| | Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction | Q75403919 |
| | Local bradykinin formation is controlled by glycosaminoglycans | Q81099306 |
| | Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction | Q82256240 |
| | The intrinsic pathway of coagulation is essential for thrombus stability in mice | Q82506244 |
| P433 | issue | 2 | |
| P304 | page(s) | 161-165 | |
| P577 | publication date | 2007-09-05 | |
| P1433 | published in | International Immunopharmacology | Q15751306 |
| P1476 | title | Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system | |
| P478 | volume | 8 | |